Fig. 4From: Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancerTumor immune profiling reveals a unique gene signature of tumor targeted prime/boost therapy a Hierarchical cluster analysis of intratumoral transcriptional changes between treatment group (FDR < 0.1) (n = 8–10). b Immune cell profiling across treatment group (n = 8–10). All analysis was performed using the nCounter Immune Profiling Advanced Analysis plugin for nSolverBack to article page